MedTrace Logo

Dose Ranging Study of Ivermectin Treatment Conditioner in Subjects With Head Lice Infestation

NCT00857948 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2012-03-30

Study results available
· View outcomes & findings →

Summary

This is a Phase 2 single center study designed to compare the safety, local tolerability, and efficacy of 3 strengths of ivermectin treatment conditioner to placebo.

Conditions

  • Pediculus Humanus Capitis (Head Lice)

Interventions

DRUG

ivermectin treatment conditioner

Application followed by thorough rinsing of the hair and scalp with water.

DRUG

Placebo, vehicle control

Application followed by thorough rinsing of the hair and scalp with water.

Sponsors & Collaborators

  • Topaz Pharmaceuticals Inc

    lead INDUSTRY

Principal Investigators

  • Medical Director · Sanofi Topaz

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2009-04-30
Completion
2009-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00857948 on ClinicalTrials.gov